Hani Goodarzi receives the Vilcek Prize for Creative Promise in Biomedical Science for using modeling and computational methods to uncover novel molecular players and pathways and therapeutic targets in cancer metastasis and for developing sophisticated molecular tools for the early detection and monitoring of cancer.
Kıvanç Birsoy receives the Vilcek Prize for Creative Promise in Biomedical Science for developing cutting-edge tools to unravel the altered metabolism of cancer cells and uncovering molecular targets for treatment.
Angelika Amon (1967-2020) receives the Vilcek Prize in Biomedical Science for groundbreaking research on the molecular signals that regulate cell growth and division, and how errors in these processes contribute to birth defects and cancer.
Ruslan Medzhitov receives the Vilcek Prize in Biomedical Science for pathbreaking work in discovering how immune system proteins called Toll-like receptors shape adaptive immunity, with wide-ranging implications for the fundamental understanding and treatment of inflammation, allergies, and cancer.
Joanna Wysocka receives the Vilcek Prize for Creative Promise in Biomedical Science for uncovering epigenetic mechanisms underlying cell self-renewal and differentiation in work that carries implications for understanding diverse biological processes, including cancer metastasis and embryonic development.
Titia de Lange receives the Vilcek Prize in Biomedical Science for seminal contributions to the biology of telomeres—the aiglet-like structures that protect the ends of chromosomes in living cells—and for discovering telomere-binding proteins that help ensure genome stability and prevent tumor formation.
Yibin Kang receives the Vilcek Prize for Creative Promise in Biomedical Science for identifying novel genes involved in cancer metastasis, unraveling dynamic interactions between tumor cells and their microenvironments, and uncovering the role of stem cells, microRNAs, and other noncoding RNAs in cancer.
Alexander Varshavsky receives the Vilcek Prize in Biomedical Science for fundamental insights into the role of regulated protein degradation and the ubiquitin system in controlling protein levels within cells, with implications for an array of diseases, including cancer.
Howard Chang receives the Vilcek Prize for Creative Promise in Biomedical Science for illuminating the role of long noncoding RNA molecules in regulating gene expression and cell fates, with potential therapeutic implications for a variety of human diseases, including cancer.